• Hindi
  • Heritage Edge
  • Sports Edge
  • Wildlife Edge
SHARP. BITTER. NEUTRAL.
No Result
View All Result
  • Login
The Edge Media
Thursday, October 2, 2025
  • Home
  • National Edge
  • State Edge
  • Political Edge
  • World Edge
  • Entertainment Edge
  • Business Edge
  • Sports Edge
  • Home
  • National Edge
  • State Edge
  • Political Edge
  • World Edge
  • Entertainment Edge
  • Business Edge
  • Sports Edge
No Result
View All Result
The Edge Media
No Result
View All Result
Home Health & Medical

US FDA withdraws emergency use authorization, after Trump calls HCQ a ‘game-changer’ drug against COVID-19,

The Edge Media by The Edge Media
5 years ago
in Health & Medical, Main Story, World Edge
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedInShare via TelegramSend To WhatsApp

The US food and drug regulatory body on Monday withdrew the emergency use authorisation of anti-malarial drugs chloroquine and hydroxychloroquine in the treatment of COVID-19 patients after concluding that they may not be effective to cure the virus infections and lead to greater risks than any potential benefits.

The Food and Drug Administration’s decision came weeks after President Donald Trump called hydroxychloroquine a “game-changer” drug in the fight against the COVID-19 in America, the world’s worst-hit nation by the pandemic.

The Food and Drug Administration (FDA) said its decision is based on new information, including clinical trial data results, that have led it to conclude that the drugs may not be effective to treat COVID-19 and that its potential benefits for such use do not outweigh its known and potential risks.

According to AP, FDA, citing reports of heart complications, said the drugs pose a greater risk to patients than any potential benefits.

The drugs can cause heart rhythm problems, severely low blood pressure and muscle or nerve damage.

FDA chief scientist Denise Hinton, in a letter dated June 15 to Gary Disbrow of Biomedical Advanced Research and Development Authority (BARDA), said as of the date of this letter, the oral formulations of hydroxychloroquine (HCQ) and (chloroquine) CQ are no longer authorised by the FDA to treat COVID-19.

On March 28, FDA had issued emergency use authorization (EUA) for use of oral formulations of chloroquine phosphate (CQ) and hydroxychloroquine sulfate (HCQ) to be distributed from the Strategic National Stockpile (SNS).

Hinton said that FDA now believes that the suggested dosing regimens for CQ and HCQ are unlikely to produce an antiviral effect.

“Earlier observations of decreased viral shedding with HCQ or CQ treatment have not been consistently replicated and recent data from a randomised controlled trial assessing probability of negative conversion showed no difference between HCQ and standard of care alone,”

he said.

Current US treatment guidelines do not recommend the use of CQ or HCQ in hospitalised patients with COVID-19 outside of a clinical trial, and the NIH guidelines now recommend against such use outside of a clinical trial, the FDA said.

“Recent data from a large randomised controlled trial showed no evidence of benefit for mortality or other outcomes such as hospital length of stay or need for mechanical ventilation of HCQ treatment in hospitalised patients with COVID-19,”

the letter said.

Hinton said that while HCQ, that has been distributed from SNS, is no longer authorised under the EUA to treat hospitalised patients for COVID-19, FDA-approved HCQ can be distributed in interstate commerce.

Hydroxychloroquine is one of the oldest and best-known anti-malarial drugs. US President Donald Trump had called hydroxychloroquine a “game-changer” drug in the fight against COVID-19.

At Trump’s request, India in April allowed the export of 50 million HCQ tablets to treat COVID-19 patients in America.

Trump had on May 18 disclosed that he was taking hydroxychloroquine daily to ward off the deadly coronavirus.

Defending the drug, he had said that hydroxychloroquine was a “line of defence” against the coronavirus.

“It is a very powerful drug I guess but it doesn’t harm you and so I thought as a frontline defence, possibly it would be good, and I have had no impact from it,” Trump said

Adding that the antimalaria drug has received tremendous reviews from doctors all over the world. According to the Johns Hopkins University data, US has over 2.1 million COVID-19 cases with more than 115,000 deaths.

-PTI

Previous Post

US making very good progress in making Covid-19 vaccines- US President Trump

Next Post

Roll back petrol, diesel price raise if you want people to be ‘self-reliant’- Sonia Gandhi writes to PM Modi

Related News

The Edge Magazine – September 2025

The Edge Magazine – September 2025

by The Edge Media
September 3, 2025
0

What’s Next? SC Revises Stray Dog Order, Directs Sterilisation and Return but Dog Lovers, NGOs Asked to Deposit Costs

What’s Next? SC Revises Stray Dog Order, Directs Sterilisation and Return but Dog Lovers, NGOs Asked to Deposit Costs

by The Edge Media
August 23, 2025
0

The Supreme Court has revised its August 11 order on stray dogs, ruling that sterilised and vaccinated animals be released...

Supreme Court Orders Aggressive Sterilisation to Control Stray Dog Population: A Landmark Verdict Ensures Public Safety & Animal Welfare

Supreme Court Orders Aggressive Sterilisation to Control Stray Dog Population: A Landmark Verdict Ensures Public Safety & Animal Welfare

by The Edge Media
August 23, 2025
0

In a landmark verdict, the Supreme Court of India has directed aggressive sterilisation of stray dogs under the ABC Rules,...

“Marriage Is Not for Absolute Freedom” – Supreme Court’s Bold Statement on Relationships

“Marriage Is Not for Absolute Freedom” – Supreme Court’s Bold Statement on Relationships

by The Edge Media
August 23, 2025
0

In a landmark ruling, the Supreme Court stated that marriage requires compromise and responsibility, warning against unrealistic expectations of absolute...

BJP Leader Rekha Gupta Gets Z+ Security Cover Amid Threat Concerns

BJP Leader Rekha Gupta Gets Z+ Security Cover Amid Threat Concerns

by The Edge Media
August 23, 2025
0

BJP leader Rekha Gupta has been granted Z+ category security cover following intelligence warnings of threats, sparking political debate.

India to Launch First-Ever Human Space Mission ‘Gaganyaan’ in December 2025

India to Launch First-Ever Human Space Mission ‘Gaganyaan’ in December 2025

by The Edge Media
August 23, 2025
0

ISRO has announced December 2025 as the launch date for India’s first human spaceflight mission, Gaganyaan, marking a new era...

Discussion about this post

Recommended

Naveen Patnaik Passes On Congratulation Message To Indian Hockey Team

Naveen Patnaik Passes On Congratulation Message To Indian Hockey Team

4 years ago
UK PM Boris Johnson marries fiancee in secret ceremony

UK PM Boris Johnson marries fiancee in secret ceremony

4 years ago

Popular News

  • The Edge Magazine – September 2025

    The Edge Magazine – September 2025

    0 shares
    Share 0 Tweet 0
  • What’s Next? SC Revises Stray Dog Order, Directs Sterilisation and Return but Dog Lovers, NGOs Asked to Deposit Costs

    0 shares
    Share 0 Tweet 0
  • Supreme Court Orders Aggressive Sterilisation to Control Stray Dog Population: A Landmark Verdict Ensures Public Safety & Animal Welfare

    0 shares
    Share 0 Tweet 0
  • “Marriage Is Not for Absolute Freedom” – Supreme Court’s Bold Statement on Relationships

    0 shares
    Share 0 Tweet 0
  • BJP Leader Rekha Gupta Gets Z+ Security Cover Amid Threat Concerns

    0 shares
    Share 0 Tweet 0
  • Hindi
  • Heritage Edge
  • Sports Edge
  • Wildlife Edge
SHARP. BITTER. NEUTRAL.

© 2024 The Edge Media All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • National Edge
  • State Edge
  • Political Edge
  • World Edge
  • Entertainment Edge
  • Business Edge
  • Sports Edge

© 2024 The Edge Media All Rights Reserved.